Immunology

Items 1631-1640 of 1990

per page
Set Descending Direction
  1. Latanoprost
    CAS  130209-82-4
    CDX-L0069
    CDX-L0069-M01010 mg
    CHF 244.00
    CDX-L0069-M02525 mg
    CHF 489.00
    Latanoprost
  2. LIF (human) (rec.)
    AG-40B-0093
    AG-40B-0093-C01010 µg
    CHF 170.00
    AG-40B-0093-30103 x 10 µg
    CHF 335.00
    AG-40B-0093-C100100 µg
    CHF 1'010.00
    Figure: Human Leukemia Inhibitory Factor (LIF) (rec.) (AG-40B-0093) maintains pluripotency of mouse ES cells. Method: Mouse ES oct4 GFP cells were cultured for 3 days in the presence of the indicated concentrations of LIF and followed
  3. LIGHT, Soluble (human) (rec.)
    AG-40B-0009
    AG-40B-0009-C01010 µg
    CHF 145.00
    AG-40B-0009-30103 x 10 µg
    CHF 290.00
  4. Limonin
    CAS  1180-71-8
    CDX-L0280
    CDX-L0280-M05050 mg
    CHF 54.00
    Limonin
  5. Lipid A from E. coli R515 (Re) TLRpure Sterile Solution
    IAX-100-004
    IAX-100-004-C250250 µg
    CHF 133.00
    IAX-100-004-C500500 µg
    CHF 210.00
    IAX-100-004-M0011 mg
    CHF 373.00
    Lipid A from E. coli R515 (Re) TLRpure Sterile Solution
  6. Lipid A from S. minnesota R595 (Re) TLRpure Sterile Solution
    IAX-100-001
    IAX-100-001-C250250 µg
    CHF 133.00
    IAX-100-001-C500500 µg
    CHF 210.00
    IAX-100-001-M0011 mg
    CHF 373.00
    Lipid A from S. minnesota R595 (Re) TLRpure Sterile Solution
  7. Lipocalin-2 (rat) (rec.)
    AG-40A-0108
    AG-40A-0108-C01010 µg
    CHF 190.00
  8. Lovastatin
    CAS  75330-75-5
    AG-CN2-0051
    AG-CN2-0051-M0055 mg
    CHF 25.00
    AG-CN2-0051-M02525 mg
    CHF 65.00
    Lovastatin
  9. Lovastatin
    CAS  75330-75-5
    CDX-L0281
    CDX-L0281-M02525 mg
    CHF 88.00
    CDX-L0281-M100100 mg
    CHF 299.00
    Lovastatin
  10. Loxistatin acid [E-64c]
    CAS  76684-89-4
    AG-CP3-7007
    AG-CP3-7007-M0011 mg
    CHF 70.00
    AG-CP3-7007-M0055 mg
    CHF 280.00
    Loxistatin acid [E-64c]

Items 1631-1640 of 1990

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.